Risk factor status and vascular events in patients with symptomatic intracranial stenosis

Neurology

Volumn 69, Issue 22, 2007, Pages 2063-2068

  Chaturvedi, S ^a   Turan, T N ^b   Lynn, M J ^c   Kasner, S E ^d   Romano, J ^e   Cotsonis, G ^c   Frankel, M ^b   Chimowitz, M I ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTRACRANIAL STENOSIS; LIFESTYLE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STENOSIS; STROKE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

EID: 36448975884     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000279338.18776.26     Document Type: Article

References (27)

1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
2. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
3. Diaz FG. The surgical management of lesions in the vertebrobasilar circulation. In: Welch KMA CL, Reis DJ, Siesjo BK, Weir B, eds. Primer on cerebrovascular diseases. San Diego: Academic Press, 1997;570-575.
4. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003;22:106-117.
5. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al., The Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
6. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
7. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003;289:2560-2572.
8. Rubin D. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, Inc.; 1987.
9. Plehn JF, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin. Circulation 1999;99:216-223.
10. White HD, Simes RJ, Anderson NE, et al. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000;343:317-326.
11. Hess DC, Demchuk AM, Brass LM, Yatsu FM. HMGCOA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology 2000;54:790-796.
12. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
13. Grundy SM, Cleeman JI, Merz CNB, et al., for the Coordinating Committee of the National Cholesterol Education Program, Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-239.
14. Sillesen H, Amarenco P, Szarek M, et al. Atorvastatin treatment in patients with carotid stenosis is associated with a marked reduction in the risk of stroke, cardiac events, and endarterectomy: a substudy of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007;38:457.
15. Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-767.
16. Cortellaro M, Cofrancesco E, Arbustini E, et al. Atorvastatin and Thrombogenicity of the Carotid Atherosclerotic Plaque: The ATROCAP study. Thromb Haemost 2002;88:41-47.
17. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution magnetic resonance imaging. Circulation 2002;106:2884-2887.
18. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 2001;103:926-933.
19. Cannon CP, Braunwald E, McCabe CH, et al. The Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
20. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080.
21. LaRosa JC, Grundy SM, Waters DD, et al. The Treating to New Targets Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435.
22. Staessen JGJ, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000;355:865-872.
23. Gorelick PB, Richardson D, Kelly M, et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients. JAMA 2003;289:2947-2957.
24. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-486.
25. Eliasziw M, Spence JD, Barnett HJM. Carotid endarterectomy does not affect long-term blood pressure: Observations from the NASCET (North American Symptomatic Carotid Endarterectomy Trial). Cerebrovasc Dis 1998;8:20-24.
26. Wong KS. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003;34:2361-2366.
27. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM, for the Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-924.